M.Pharm

Wipro Infotech is the leading strategic IT partner for companies across India and Middle East - offering integrated IT solutions. We plan, deploy, sustain and maintain your IT lifecycle through our total outsourcing, consulting services, business solutions and professional services. Wipro Infotech helps you drive momentum in your organisation - no matter what domain you are in.

GLA Group recognizes the importance of providing world-class edification facilities in various areas of education, and GLA Institute of Pharmaceutical Research stands tall in this regard with such ideologies and philosophies deeply held and imbibed.

Syngene International is one of India’s premier contract research and manufacturing organizations in providing customized service. Our services encompasses all across discovery chain: early stage discovery, process development, cGMP manufacturing and formulation development both in the small molecule and novel biologics area.

Bengal Chemical & Pharmaceutical Works Ltd.(BCPW)  is precursor of the present Company, Bengal Chemicals & Pharmaceuticals Ltd (BCPL).  Acharya P C Ray  took a rented house at 91 Upper Circular Road, Calcutta and started business with a meager capital of Rs 700.00. Since inception of the Company he was very much quality conscious and produced various products of British Pharmacopoeia standard.

Biocon Bristol-Myers Squibb R&D Center (BBRC) in Bangalore is a state-of-the-art integrated Drug Discovery and Development facility. We are seeking best-of-breed scientists with Scientific and Managerial skills at various levels.

[adsense:336x280:8701650588]

Founded in 1985, Max India Ltd. is a Public Limited company listed on the NSE and BSE of India with over 30,000 shareholders. Max India Limited is a multi-business corporate entity driven by the spirit of enterprise with a focus on people and service oriented businesses.
Prominent shareholders of the company are Mr Analjit Singh and a leading private equity firm, Warburg Pincus. The balance shareholding is held by the public and Institutional Investors.

Umedica Laboratories Ltd.  is part of a Amoli Group of Companies, manufacturing and exporting a wide range of Injectables, tablets, capsules, suspensions, dry syrups in the categories of non-steriodal anti-inflammatory (NSAIDs), antibiotics, antifungal, analgesics, antiviral, antituberculosis agents, antihistamines, psychotropics and multivitamins etc.